logo

Lannett Co Inc (LCI)



Trade LCI now with
  Date
  Headline
1/13/2020 6:54:12 AM Lannett Announces FDA Approval Of NDA For Branded Anesthetic Product, Cocaine Hydrochloride Nasal Solution 4%
1/6/2020 6:53:25 AM Lannett Launches Venlafaxine ER Tablets And Lidocaine Topical Solution 4%
12/23/2019 6:55:12 AM Lannett Receives FDA Approvals For Butalbital, Acetaminophen And Caffeine Capsules
12/12/2019 6:59:52 AM Lannett To Commence Marketing Generic Adderall® XR In The Coming Months
12/12/2019 6:57:00 AM Lannett To Commence Marketing Generic Adderall® XR (Press Release)
12/4/2019 6:53:55 AM Lannett Announces Positive Results From First Human Study Evaluating Insulin Glargine
10/1/2019 6:54:31 AM Lannett Enters Exclusive US Distribution Agreement For Therapeutically Equivalent Generic Of ADVAIR DISKUS
9/27/2019 4:15:49 PM Lannett Announces Closing Of $86.25 Mln Of Convertible Senior Notes Due 2026
9/25/2019 7:44:05 AM Lannett Reports Pricing Of $75 Mln Of 4.50% Convertible Senior Notes Due 2026
8/28/2019 6:56:27 AM Lannett Enters Deal With Sinotherapeutics To Be Exclusive U.S. Distributor Of Posaconazole Delayed-Release Tablets 100mg
8/27/2019 4:30:04 PM Lannett Q4 Loss/share $0.20 Vs. Loss $0.30 Year Ago
8/27/2019 6:53:17 AM Lannett Enters Three-year Advisory Services Agreement With Its Strategic Alliance Partner, Cediprof
  
 
>